Parenteral Drug (India) share news and announcements
BSE: 524689Pharmaceuticals & Biotechnology
Trading suspended since 3 Feb 2025
Last traded ₹2.90 on 21 Aug 2023
Parenteral Drug (India) share news and announcements
782 announcements, routine notices left out, newest first. Page 10 of 16.
Sep 2017
Aug 2017
Jul 2017
21 Jul · Shareholding for the Period Ended June 30, 2017
Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click ....11 Jul · Statement Of Investors Complaints For The Quarter Ended 30Th June, 2017
May 2017
23 May · Notice Of Board Meeting To Consider The Audited Financial Statements (Both Standalone And Consolidated) For The Financial Year Ended On 31St March, 2017
Apr 2017
21 Apr · Shareholding for the Period Ended March 31, 2017
Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click ....18 Apr · Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended March 31, 2017.
18 Apr · Certificate Under Regulation 40(10) Of SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015
13 Apr · Statement Of Investor Complaint For The Quarter Ended 31St March, 2017
Mar 2017
22 Mar · Results
Details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....22 Mar · Meeting
Feb 2017
20 Feb · Meeting
18 Feb · Meeting
17 Feb · Limited Review Report for December 31, 2016
16 Feb · Limited Review Report
13 Feb · Board meeting
Jan 2017
19 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
18 Jan · Shareholding for the Period Ended December 31, 2016
Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click ....
Nov 2016
15 Nov · Legal
Exchange has sought clarification from Parenteral Drugs (India) Limited with respect to announcement dated 14-Nov-2016, regarding "Parenteral Drugs (India) Limited has informed the Exchange that the Board of Directors of the Company at their meeting held on November 14, 2016 had considered & approved the appointment of Mr. Sandeep Vyas as an additional and Independent director on the Board of the Company.".On basis of above the Company is required to clarify following:1. Brief profile (in case of appointment);2. Disclosure of relationships between directors (in case of appointment of a director).The response of the Company is awaited.
Oct 2016
21 Oct · Board meeting
21 Oct · Shareholding for the Period Ended September 30, 2016
Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click ....